SPYRE THERAPEUTICS, INC. Finance Lease, Principal Payments
SPYRE THERAPEUTICS, INC. (SYRE) reported Finance Lease, Principal Payments of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Cash Flow › Financing Activities
us-gaap:FinanceLeasePrincipalPayments · last filed 2025-02-27
- SPYRE THERAPEUTICS, INC. finance lease, principal payments for the quarter ending 2024-12-31 was $0.00.
- SPYRE THERAPEUTICS, INC. finance lease, principal payments for the quarter ending 2024-09-30 was $0.00.
- SPYRE THERAPEUTICS, INC. finance lease, principal payments for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- SPYRE THERAPEUTICS, INC. finance lease, principal payments for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- SPYRE THERAPEUTICS, INC. finance lease, principal payments for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- SPYRE THERAPEUTICS, INC. finance lease, principal payments for fiscal 2023 was $16.00K, a 96.17% decline from fiscal 2022.
- SPYRE THERAPEUTICS, INC. finance lease, principal payments for fiscal 2022 was $418.00K, a 18.04% decline from fiscal 2021.
- SPYRE THERAPEUTICS, INC. finance lease, principal payments for fiscal 2021 was $510.00K, a 2450.00% increase from fiscal 2020.
| Period end | Finance Lease, Principal Payments 3 month | Finance Lease, Principal Payments 6 month | Finance Lease, Principal Payments 9 month | Finance Lease, Principal Payments 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $0.00 derived: sum of 3 quarters · filed 2025-02-27 | $0.00 10-K · filed 2025-02-27 |
| 2024-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2024-11-18 | $0.00 derived: sum of 2 quarters · filed 2024-11-18 | $0.00 10-Q/A · filed 2024-11-18 | $0.00 derived: sum of 4 quarters · filed 2025-02-27 |
| 2024-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-11-18 | $0.00 10-Q/A · filed 2024-11-18 | $0.00 derived: sum of 3 quarters · filed 2025-02-27 | $0.00 derived: sum of 4 quarters · filed 2025-02-27 |
| 2024-03-31 | $0.00 10-Q/A · filed 2024-11-18 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $0.00 derived: sum of 3 quarters · filed 2025-02-27 | $8.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $8.00K derived: sum of 3 quarters · filed 2025-02-27 | $16.00K 10-K · filed 2025-02-27 |
| 2023-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2024-11-18 | $8.00K derived: sum of 2 quarters · filed 2024-11-18 | $16.00K 10-Q/A · filed 2024-11-18 | $24.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $8.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-11-18 | $16.00K 10-Q/A · filed 2024-11-18 | $24.00K derived: sum of 3 quarters · filed 2025-02-27 | $87.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $8.00K 10-Q/A · filed 2024-11-18 | $16.00K derived: sum of 2 quarters · filed 2025-02-27 | $79.00K derived: sum of 3 quarters · filed 2025-02-27 | $254.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $71.00K derived: sum of 2 quarters · filed 2025-02-27 | $246.00K derived: sum of 3 quarters · filed 2025-02-27 | $418.00K 10-K · filed 2025-02-27 |
| 2022-09-30 | $63.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $238.00K derived: sum of 2 quarters · filed 2023-11-09 | $410.00K 10-Q · filed 2023-11-09 | $579.00K derived: sum of 4 quarters · filed 2024-11-18 |
| 2022-06-30 | $175.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $347.00K 10-Q · filed 2023-08-11 | $516.00K derived: sum of 3 quarters · filed 2024-11-18 | $624.00K derived: sum of 4 quarters · filed 2024-11-18 |
| 2022-03-31 | $172.00K 10-Q · filed 2023-05-11 | $341.00K derived: sum of 2 quarters · filed 2024-11-18 | $449.00K derived: sum of 3 quarters · filed 2024-11-18 | $677.00K derived: sum of 4 quarters · filed 2024-11-18 |
| 2021-12-31 | $169.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-11-18 | $277.00K derived: sum of 2 quarters · filed 2024-11-18 | $505.00K derived: sum of 3 quarters · filed 2024-11-18 | $510.00K 10-K/A · filed 2024-11-18 |
| 2021-09-30 | $108.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $336.00K derived: sum of 2 quarters · filed 2022-11-03 | $341.00K 10-Q · filed 2022-11-03 | $347.00K derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-06-30 | $228.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $233.00K 10-Q · filed 2022-08-04 | $239.00K derived: sum of 3 quarters · filed 2023-03-02 | $245.00K derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-03-31 | $5.00K 10-Q · filed 2022-05-05 | $11.00K derived: sum of 2 quarters · filed 2023-03-02 | $17.00K derived: sum of 3 quarters · filed 2023-03-02 | $18.00K derived: sum of 4 quarters · filed 2023-03-02 |
| 2020-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $12.00K derived: sum of 2 quarters · filed 2023-03-02 | $13.00K derived: sum of 3 quarters · filed 2023-03-02 | $20.00K 10-K · filed 2023-03-02 |
| 2020-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $7.00K derived: sum of 2 quarters · filed 2021-11-04 | $14.00K 10-Q · filed 2021-11-04 | $21.00K derived: sum of 4 quarters · filed 2022-03-08 |
| 2020-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $8.00K 10-Q · filed 2021-08-05 | $15.00K derived: sum of 3 quarters · filed 2022-03-08 | $21.00K derived: sum of 4 quarters · filed 2022-03-08 |
| 2020-03-31 | $7.00K 10-Q · filed 2021-05-10 | $14.00K derived: sum of 2 quarters · filed 2022-03-08 | $20.00K derived: sum of 3 quarters · filed 2022-03-08 | $26.00K derived: sum of 4 quarters · filed 2022-03-08 |
| 2019-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $13.00K derived: sum of 2 quarters · filed 2022-03-08 | $19.00K derived: sum of 3 quarters · filed 2022-03-08 | $25.00K 10-K · filed 2022-03-08 |
| 2019-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $12.00K derived: sum of 2 quarters · filed 2020-11-05 | $18.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $12.00K 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $6.00K 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |